Aster DM Healthcare Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on March 10, 2026. Further, the company has informed the Exchange regarding voting results.
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aster DM Healthcare informed the exchanges about the voting results of the NCLT-convened meeting of equity shareholders held on March 10, 2026, to approve the Scheme of Amalgamation with Quality Care India Limited (QCIL) under Sections 230-232 of the Companies Act, 2013. Out of 51.81 crore total shares, 48.18 crore (93%) were polled, with 96.68% voting in favour and only 3.32% against the scheme. Promoters voted 100% in favour, while public institutional and non-institutional shareholders voted 92.76% and 99.99% in favour respectively. Public shareholders (excluding promoters) approved the scheme with 94.13% votes in favour, satisfying both the three-fourths majority requirement and SEBI's public shareholder threshold. The scheme now awaits final NCLT sanction for effective implementation.
This is a significant positive step towards the consolidation of Quality Care India Limited into Aster DM Healthcare, which would expand Aster's hospital and healthcare footprint in India. Shareholders have overwhelmingly approved the deal, and the next key milestone is the final NCLT approval, which could unlock synergies and potentially boost long-term value for Aster DM shareholders.